zatebradine has been researched along with Dilatation, Pathologic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ertl, G; Fraccarollo, D; Gaudron, P; Hu, K; Kaden, JJ; Naumann, A; Neubauer, S | 1 |
1 other study(ies) available for zatebradine and Dilatation, Pathologic
| Article | Year |
|---|---|
Heart rate reduction by zatebradine reduces infarct size and mortality but promotes remodeling in rats with experimental myocardial infarction.
Topics: Animals; Benzazepines; Body Weight; Cardiotonic Agents; Catecholamines; Chromatography, High Pressure Liquid; Creatine Kinase; Dilatation, Pathologic; Dose-Response Relationship, Drug; Energy Metabolism; Female; Heart Rate; Hemodynamics; Hormones; Isoenzymes; L-Lactate Dehydrogenase; Myocardial Infarction; Myocardium; Oxygen Consumption; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Remodeling | 2004 |